Theranos failed a second major U.S. regulatory inspection of its laboratory facilities, people familiar with the situation said, a setback the Silicon Valley blood-testing firm hasn’t disclosed to investors or patients. ... read more
We use cookies to ensure that we give you the best experience on our website. Continuing to use this site assumes you accept the use of cookies. OkPrivacy Policy